Catheter Precision (VTAK) announced that it has entered into securities purchase agreements with institutional investors for a $1.5M private placement equity financing and the acquisition of certain promissory notes of QHSLab. Ladenburg Thalmann & Co. acted as exclusive placement agent for these transactions.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTAK:
- Catheter Precision Finalizes Strategic Cardiac Acquisition
- Catheter Precision completes acquisition of Cardionomic heart failure assets
- Catheter Precision announces clinical data about VIVO to be presented
- Catheter Precision to acquire assets of Cardionomic related to CPNS system
- Catheter Precision receives notice of first patent allowance in US for LockeT